
|Articles|December 18, 2015
Isis Pharmaceuticals Changes Company Name
December 18, 2015.
Advertisement
Isis Pharmaceuticals (Arlsbad, CA) today announced that the company has changed its name to Ionis Pharmaceuticals (pronounced "eye-OH-nis") for obvious reasons.
Lynne Parshall, chief operating officer at Ionis, said: "We decided to change our company name because, when people see or hear our name, we want them to think about the life-saving medicines we are developing."
In conjunction with the corporate name change, the company will trade on the NASDAQ Global Select Market under the new ticker symbol "IONS". In addition, it has a new website address:
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics
2
The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan
3
FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease
4
Educating Patients About GLP-1s: Q&A with Kristen Hartzell, PharmD
5



